249 related articles for article (PubMed ID: 27460732)
1. Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
Zhou Y; Wang DL; Pang Q
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3035-9. PubMed ID: 27460732
[TBL] [Abstract][Full Text] [Related]
2. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.
Liu H; Lv Z; Guo E
Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
7. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
[TBL] [Abstract][Full Text] [Related]
8. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
[TBL] [Abstract][Full Text] [Related]
10. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CPS1-IT1 serves as anti-oncogenic role in glioma.
Chen H; Li Q; Liang J; Jin M; Lu A
Biomed Pharmacother; 2019 Oct; 118():109277. PubMed ID: 31545272
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
[TBL] [Abstract][Full Text] [Related]
16. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
17. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
Li J; Chen Y; Chen Z; He A; Xie H; Zhang Q; Cai Z; Liu Y; Huang W
Tumour Biol; 2017 Jun; 39(6):1010428317711406. PubMed ID: 28651500
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
[TBL] [Abstract][Full Text] [Related]
19. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Yu J; Han Q; Cui Y
Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
[TBL] [Abstract][Full Text] [Related]
20. [Effect of long noncoding RNA SPRY4-IT1 on proliferation and metastasis of medulloblastoma].
Shi PF; Ji HL; Luo YK; Mao TM; Chen X; Zhou KY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):78-82. PubMed ID: 29926610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]